Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fortive CorpFTV · Entity 3303 | Director | June 09, 2026 | June 11, 2026 |
| Queen's Gambit Growth CapitalGMBT · Entity 143674 | Director | January 19, 2021 | January 20, 2021 |
| SYNOPSYS INCSNPS · Entity 210 | Director | April 16, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fortive Corp
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,754 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,350 · Balance 27,754 F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting.
Queen's Gambit Growth Capital
Report date January 19, 2021 · Filed January 20, 2021
This filing explicitly reported no securities owned.
SYNOPSYS INC
Report date April 16, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,997 |
Reported balance
After 2026-04-16 transaction · row 1
1 source rowRow 1 · 2026-04-16 · Grant · Acquired 453 · Balance 2,997 F1: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2: Automatic award under the Amended and Restated Equity Incentive Plan. |
| Common StockSEC Table I · non-derivative | Indirectby Family Trust | 445 |
Reported balance
Holding disclosure · report date 2026-04-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 445 |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.
F2: Automatic award under the Amended and Restated Equity Incentive Plan.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYPRESS SEMICONDUCTOR CORP /DE/
Report date April 16, 2020 · Filed April 17, 2020
Section 16 reporting ended · disclosed 2020-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 1
1 source rowRow 1 · 2020-04-16 · Disposition to issuer · Disposed 26,233 · Balance 0 F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-16 · Disposition to issuer · Disposed 4,270 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units that vest in three equal annual installments beginning on December 18, 2018. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-16 · Disposition to issuer · Disposed 11,383 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest.
F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement.
F3: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units that vest in three equal annual installments beginning on December 18, 2018.
F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement.
F5: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders.
Proterra Inc
Report date March 13, 2024 · Filed March 13, 2024
Section 16 reporting ended · disclosed 2024-03-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-03-13 transaction · row 1
1 source rowRow 1 · 2024-03-13 · Other · Disposed 41,060 · Balance 0 F1: On August 7, 2023, Proterra Inc (the "Company") and its subsidiary Proterra Operating Company, Inc. (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Court"), thereby commencing chapter 11 cases for the Debtors. On March 6, 2024, the Court entered its order confirming the Fifth Amended Joint Chapter 11 Plan of Reorganization for Proterra Inc and its Debtor Affiliate (the "Plan"). On March 13, 2024, the Plan became effective pursuant to its terms (the "Effective Date"). On the Effective Date, pursuant to the Plan, all outstanding shares of the Company's common stock, including options, warrants, rights, restricted stock units or other securities or agreements to acquire such common stock, were cancelled and extinguished without the receipt of any consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 7, 2023, Proterra Inc (the "Company") and its subsidiary Proterra Operating Company, Inc. (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Court"), thereby commencing chapter 11 cases for the Debtors. On March 6, 2024, the Court entered its order confirming the Fifth Amended Joint Chapter 11 Plan of Reorganization for Proterra Inc and its Debtor Affiliate (the "Plan"). On March 13, 2024, the Plan became effective pursuant to its terms (the "Effective Date"). On the Effective Date, pursuant to the Plan, all outstanding shares of the Company's common stock, including options, warrants, rights, restricted stock units or other securities or agreements to acquire such common stock, were cancelled and extinguished without the receipt of any consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 20:50 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001331845-26-000005 · wk-form4_1781211019.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,754 F1 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 23:30 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001331845-26-000003 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,997 F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2 · kind: Automatic award under the Amended and Restated Equity Incentive Plan. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,140 | $0.00 Strike: $70.26 | $0.00 |
DisclosureSEC source: 0001659166-25-000085 · wk-form4_1749081688.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Underlying: Common Stock · 2,140 shares Expires 2035-06-02 Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-25-000085 · wk-form4_1749081688.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,001 F1 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| April 10, 2025 Filed Apr 14, 2025 20:22 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 491 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-25-000052 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,544 F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:10 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,990 | $0.00 Strike: $72.95 | $0.00 |
DisclosureSEC source: 0001659166-24-000121 · wk-form4_1717632607.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 1,990 shares Expires 2034-06-03 Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:10 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-24-000121 · wk-form4_1717632607.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,881 F1 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 16:50 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 356 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-24-000058 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,053 F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan. Read SEC document |
| March 13, 2024 Filed Mar 13, 2024 23:15 UTC | Proterra Inc PTRAQ · Entity 93081 | OtherCommon Stock | 41,060 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-24-000687 · es240456684_4-sargent.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On August 7, 2023, Proterra Inc (the "Company") and its subsidiary Proterra Operating Company, Inc. (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Court"), thereby commencing chapter 11 cases for the Debtors. On March 6, 2024, the Court entered its order confirming the Fifth Amended Joint Chapter 11 Plan of Reorganization for Proterra Inc and its Debtor Affiliate (the "Plan"). On March 13, 2024, the Plan became effective pursuant to its terms (the "Effective Date"). On the Effective Date, pursuant to the Plan, all outstanding shares of the Company's common stock, including options, warrants, rights, restricted stock units or other securities or agreements to acquire such common stock, were cancelled and extinguished without the receipt of any consideration. F1 · price: On August 7, 2023, Proterra Inc (the "Company") and its subsidiary Proterra Operating Company, Inc. (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the "Court"), thereby commencing chapter 11 cases for the Debtors. On March 6, 2024, the Court entered its order confirming the Fifth Amended Joint Chapter 11 Plan of Reorganization for Proterra Inc and its Debtor Affiliate (the "Plan"). On March 13, 2024, the Plan became effective pursuant to its terms (the "Effective Date"). On the Effective Date, pursuant to the Plan, all outstanding shares of the Company's common stock, including options, warrants, rights, restricted stock units or other securities or agreements to acquire such common stock, were cancelled and extinguished without the receipt of any consideration. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:36 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,310 | $0.00 Strike: $67.23 | $0.00 |
DisclosureSEC source: 0001659166-23-000154 · wk-form4_1686260208.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2033-06-06 Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:36 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-23-000154 · wk-form4_1686260208.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,911 F1 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 17:31 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001517737-23-000029 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,697 F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 23:23 UTC | Proterra Inc PTRA · Entity 93081 | GrantCommon Stock | 33,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021726 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,764 F1 · shares: Represents the number of shares of common stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. 25% of the total shares underlying the RSUs will vest quarterly on March 31, June 30, September 30, and December 31 (each a "Quarterly Vesting Date"), provided however, that if Reporting Person resigns, retires, or is removed from the Issuer's Board of Directors ("Board") before a Quarterly Vesting Date, then for the quarter in which the Reporting Person ceases Service (as defined in the Issuer's 2021 Equity Incentive Plan ("EIP")), the shares will vest daily (i.e., over the number of days in the year) in the quarter such that the shares vest for each day the Reporting Person provided services, and RSUs which have not been previously settled during the Reporting Person's term of office will be settled upon the Reporting Person's departure from the Board pursuant to the terms of the EIP. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:26 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 3,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000120 · wf-form4_165471997094533.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,621 F1 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 21:10 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001199719-22-000030 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233 F1 · date: Vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to continued Board service through such date. F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:02 UTC | Proterra Inc PTRA · Entity 93081 | GrantCommon Stock | 12,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011866 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,357 F1 · balance_after: Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:43 UTC | Proterra Inc PTRA · Entity 93081 | GrantCommon Stock | 8,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067365 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,731 F1 · balance_after: Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met. Read SEC document |
| July 20, 2021 Filed Jul 23, 2021 00:46 UTC | Proterra Inc PTRA · Entity 93081 | GrantCommon Stock | 2,919 | $8.93 | $26,052.08 |
DisclosureSEC source: 0001209191-21-047885 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,919 F1 · kind: On July 19, 2021, Issuer determined that the reporting person became entitled to receive these shares of common stock pursuant to the earnout provision set forth in Section 3.09(a)(i) of the Agreement and Plan of Merger, dated as of January 11, 2021, by and among Proterra Inc (formerly ArcLight Clean Transition Corp.), Phoenix Merger Sub, Inc., and Proterra Operating Company, Inc. (formerly Proterra Inc) (the "Merger Agreement"). The price per share indicated on this form is based on the deemed value of the common stock on the date the Merger Agreement was signed. The right of the reporting person to receive additional shares became fixed and irrevocable on June 14, 2021, the effective date of the merger. F1 · shares: On July 19, 2021, Issuer determined that the reporting person became entitled to receive these shares of common stock pursuant to the earnout provision set forth in Section 3.09(a)(i) of the Agreement and Plan of Merger, dated as of January 11, 2021, by and among Proterra Inc (formerly ArcLight Clean Transition Corp.), Phoenix Merger Sub, Inc., and Proterra Operating Company, Inc. (formerly Proterra Inc) (the "Merger Agreement"). The price per share indicated on this form is based on the deemed value of the common stock on the date the Merger Agreement was signed. The right of the reporting person to receive additional shares became fixed and irrevocable on June 14, 2021, the effective date of the merger. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:52 UTC | Proterra Inc PTRA · Entity 93081 | GrantStock Option (Right to Buy) · Derivative | 20,081 | Not disclosed Strike: $4.78 | Not disclosed |
DisclosureSEC source: 0001209191-21-041199 · doc4.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,081 Underlying: Common Stock · 20,081 shares Expires 2030-12-20 F2 · price: Pursuant to the business combination of ArcLight Clean Transition Corp. and Proterra Inc ("Old Proterra"), each share of Old Proterra outstanding common stock was automatically converted into the right to shares of the Issuer's Common Stock based on a 1 to 0.8925 conversion ratio ("Conversion Ratio"). In addition, each outstanding Old Proterra equity award was automatically converted into a corresponding equity award of the Issuer based on the Conversion Ratio and with the same terms and vesting conditions as the Old Proterra equity awards. F4 · derivative.exercise_date: 1/48 of the total shares underlying the option vest monthly beginning on January 21, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:52 UTC | Proterra Inc PTRA · Entity 93081 | GrantStock Option (Right to Buy) · Derivative | 44,625 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001209191-21-041199 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,625 Underlying: Common Stock · 44,625 shares Expires 2029-12-22 F2 · price: Pursuant to the business combination of ArcLight Clean Transition Corp. and Proterra Inc ("Old Proterra"), each share of Old Proterra outstanding common stock was automatically converted into the right to shares of the Issuer's Common Stock based on a 1 to 0.8925 conversion ratio ("Conversion Ratio"). In addition, each outstanding Old Proterra equity award was automatically converted into a corresponding equity award of the Issuer based on the Conversion Ratio and with the same terms and vesting conditions as the Old Proterra equity awards. F3 · derivative.exercise_date: 1/48 of the total shares underlying the option vest monthly beginning on January 23, 2020 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:52 UTC | Proterra Inc PTRA · Entity 93081 | GrantStock Option (Right to Buy) · Derivative | 200,812 | Not disclosed Strike: $5.41 | Not disclosed |
DisclosureSEC source: 0001209191-21-041199 · doc4.xml · derivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,812 Underlying: Common Stock · 200,812 shares Expires 2028-11-15 F2 · price: Pursuant to the business combination of ArcLight Clean Transition Corp. and Proterra Inc ("Old Proterra"), each share of Old Proterra outstanding common stock was automatically converted into the right to shares of the Issuer's Common Stock based on a 1 to 0.8925 conversion ratio ("Conversion Ratio"). In addition, each outstanding Old Proterra equity award was automatically converted into a corresponding equity award of the Issuer based on the Conversion Ratio and with the same terms and vesting conditions as the Old Proterra equity awards. F1 · derivative.exercise_date: 1/48 of the total shares underlying the option vest monthly beginning on November 18, 2018 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:04 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-21-000166 · wf-form4_162335903460128.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,606 F1 · shares: On June 8, 2021, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary of the grant date following the Reporting Person's retirement from the Board of Directors of the Issuer. F2 · balance_after: In connection with the spin-off of Vontier Corporation by the Issuer, outstanding Restricted Stock Units ("RSUs"), including RSUs previously granted to the Reporting Person, were subject to anti-dilution adjustments ("Anti-Dilution Adjustment"). To the extent that the outstanding RSUs granted to the Reporting Person were previously reported under Table I, the total number of shares reported include the additional RSUs held by the Reporting Person as a result of the Anti-Dilution Adjustment. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 21:48 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 670 | $0.00 | $0.00 |
DisclosureSEC source: 0001199719-21-000036 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date. F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 16:57 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 5,998 | $0.00 Strike: $229.36 | $0.00 |
DisclosureSEC source: 0001199719-20-000100 · edgardoc.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,998 Underlying: Common Stock · 5,998 shares Expires 2027-09-02 F2 · kind: Grant to reporting person to buy shares of common stock under the 2017 Non-Employee Directors Equity Incentive Plan F3 · derivative.exercise_date: Vest in three (3) successive equal installments through the date immediately preceding each of the first three (3) Annual Meetings following the Date of Grant, subject to continued Board service through each such date. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 16:57 UTC | SYNOPSYS INC SNPS · Entity 210 | GrantCommon Stock | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001199719-20-000100 · edgardoc.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445 F1 · date: Vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to continued Board service through such date. F2 · kind: Grant to reporting person to buy shares of common stock under the 2017 Non-Employee Directors Equity Incentive Plan Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:20 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $62.17 | $0.00 |
DisclosureSEC source: 0001659166-20-000095 · wf-form4_159121558756172.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2030-06-01 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:20 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,910 | $58.93 | $112,556.30 |
DisclosureSEC source: 0001659166-20-000095 · wf-form4_159121558756172.xml · nonDerivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,885 F2 · shares: On June 1, 2020, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $58.93, pursuant to deferral election made by the Reporting Person of $112,500 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2021 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. F2 · price: On June 1, 2020, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $58.93, pursuant to deferral election made by the Reporting Person of $112,500 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2021 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:20 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-20-000095 · wf-form4_159121558756172.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,975 F1 · shares: On June 1, 2020, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2021 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:16 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerRestricted Stock Units · Derivative | 11,383 | $23.85 | $271,484.55 |
DisclosureSEC source: 0001209191-20-024792 · doc4.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,383 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5 · derivative.exercise_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. F5 · derivative.expiration_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units that vest on the day before the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:16 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerRestricted Stock Units · Derivative | 4,270 | $23.85 | $101,839.50 |
DisclosureSEC source: 0001209191-20-024792 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,270 shares Expires not disclosed F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3 · derivative.exercise_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units that vest in three equal annual installments beginning on December 18, 2018. F3 · derivative.expiration_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units that vest in three equal annual installments beginning on December 18, 2018. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:16 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Disposition to issuerCommon Stock | 26,233 | $23.85 | $625,657.05 |
DisclosureSEC source: 0001209191-20-024792 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 16:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061318 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,270 Underlying: Common Stock · 4,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units upon the effectiveness of her appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on December 18, 2018. F2 · derivative.expiration_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units upon the effectiveness of her appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on December 18, 2018. Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 16:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061318 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 23:30 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 3,340 | $0.00 Strike: $77.77 | $0.00 |
DisclosureSEC source: 0001659166-19-000150 · wf-form4_155977742936926.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,340 Underlying: Common Stock · 3,340 shares Expires 2029-06-04 Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 23:30 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,385 | $79.52 | $110,135.20 |
DisclosureSEC source: 0001659166-19-000150 · wf-form4_155977742936926.xml · nonDerivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 F2 · shares: On June 4, 2019, the Issuer granted to the Reporting Person restricted stock units ("Deferral RSUs") of the Issuer in the amount indicated, based on a 20-day average price of $79.52, pursuant to deferral election made by the Reporting Person of $110,000 in annual retainer that would otherwise have been paid in cash. Since the Deferral RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Deferral RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2020 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 23:30 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-19-000150 · wf-form4_155977742936926.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105 F1 · shares: On June 4, 2019, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2020 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| May 03, 2019 Filed May 6, 2019 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 11,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027879 · doc4.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,383 Underlying: Common Stock · 11,383 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2019 annual meeting of stockholders (the "2019 Annual Equity Grant"), which are scheduled to vest on the day before the Issuer's 2020 annual meeting of stockholders. F3 · derivative.expiration_date: On May 3, 2019, the Reporting Person was granted 11,383 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2019 annual meeting of stockholders (the "2019 Annual Equity Grant"), which are scheduled to vest on the day before the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027879 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On May 11, 2018, the Reporting Person was granted 12,353 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"), which were scheduled to vest on the day before the Issuer's 2019 annual meeting of stockholders. F2 · derivative.expiration_date: On May 11, 2018, the Reporting Person was granted 12,353 restricted stock units under the Issuer's 2013 Stock Plan upon being elected to the Issuer's board of directors at the 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"), which were scheduled to vest on the day before the Issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:40 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-027879 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| December 18, 2018 Filed Dec 18, 2018 20:53 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063371 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,541 Underlying: Common Stock · 4,271 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units upon the effectiveness of her appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on December 18, 2018. F2 · derivative.expiration_date: On December 18, 2017, the Reporting Person was granted 12,812 restricted stock units upon the effectiveness of her appointment to the Issuer's board of directors and in accordance with the Issuer's non-employee director compensation policy (the "2017 Initial Equity Grant"). This 2017 Initial Equity Grant vests in three equal annual installments beginning on December 18, 2018. Read SEC document |
| December 18, 2018 Filed Dec 18, 2018 20:53 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063371 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| May 11, 2018 Filed May 14, 2018 20:15 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 12,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030075 · doc4.xml · derivative · entry 3 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,353 Underlying: Common Stock · 12,353 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On May 11, 2018, the Reporting Person was awarded a grant of 12,353 restricted stock units upon election to the Issuer's board of directors at the Issuer's 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"). This 2018 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2019 annual meeting of stockholders. F3 · derivative.expiration_date: On May 11, 2018, the Reporting Person was awarded a grant of 12,353 restricted stock units upon election to the Issuer's board of directors at the Issuer's 2018 annual meeting of stockholders (the "2018 Annual Equity Grant"). This 2018 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2019 annual meeting of stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:15 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 5,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030075 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 18, 2017, the Reporting Person was awarded a grant of 5,338 restricted stock units upon her appointment to the Issuer's board of directors on December 18, 2017 (the "2017 Annual Equity Grant"). The number of restricted stock units underlying this 2017 Annual Equity Grant was prorated to reflect the Reporting Person's appointment date to the Issuer's board of directors. This 2017 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2018 annual meeting of stockholders. F2 · derivative.expiration_date: On December 18, 2017, the Reporting Person was awarded a grant of 5,338 restricted stock units upon her appointment to the Issuer's board of directors on December 18, 2017 (the "2017 Annual Equity Grant"). The number of restricted stock units underlying this 2017 Annual Equity Grant was prorated to reflect the Reporting Person's appointment date to the Issuer's board of directors. This 2017 Annual Equity Grant to non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 20:15 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 5,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030075 · doc4.xml · nonDerivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 16:47 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 5,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066385 · doc4.xml · derivative · entry 2 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,338 Underlying: Common Stock · 5,338 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F4 · date: Acquired upon the initial appointment of the Reporting Person to the Issuer's board of directors on December 18, 2017 (the "Annual Equity Grant"). F5 · shares: This Annual Equity Grant to the Reporting Person was pro-rated to a grant date value of approximately $83,333 (from $200,000) to reflect her December 18, 2017 initial appointment to the Issuer's board of directors. F6 · derivative.exercise_date: This Annual Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's next annual meeting of stockholders. F6 · derivative.expiration_date: This Annual Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and is fully vested on the day before the Issuer's next annual meeting of stockholders. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 16:47 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 12,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066385 · doc4.xml · derivative · entry 1 Sargent Jeannine P · CIK 0001331845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,812 Underlying: Common Stock · 12,812 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F2 · date: Acquired upon the initial appointment of the Reporting Person to the Issuer's board of directors on December 18, 2017 (the "Initial Equity Grant"). F3 · derivative.exercise_date: This Initial Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and will vest in three equal annual installments beginning on December 18, 2018. F3 · derivative.expiration_date: This Initial Equity Grant to the non-employee members of the Issuer's board of directors represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting and will vest in three equal annual installments beginning on December 18, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.